One of the Three Largest Heart Transplant Programs in the Nation
The RWJBarnabas Health Heart Failure and Transplant program is the most
experienced and comprehensive program in New Jersey and is one of the
three largest heart transplant programs in the nation. It has been at
the forefront of highly specialized care for more than thirty years. Our
cardiac surgeons and heart specialists' expertise has made RWJBarnabas
Health a regional and national training center for physicians, nurses
and emergency services technicians.
Choose RWJBarnabas Health for Heart Transplant
Our heart transplant program survival rates consistently meet or exceed
national benchmarks. Our centers are at the forefront of improving the
quality of life for transplant candidates and recipients, as well as increasing
access to transplant. Our unique work in establishing successful protocols
for discontinuing steroid medications for immunosuppression is improving
the medical management and survival rates for transplant recipients worldwide.
Noninvasive gene expression testing offers an alternative technique for
assessing immunosuppression and predicting rejection. Our centers are
also part of groundbreaking research that is exploring innovating methods
for preserving donor organs for transplant.
Barbara Schempp: A Heart Transplant Gives New Hope
Complete Transplant Care
The RWJBarnabas Health Heart Centers provide progressive heart failure
management that optimizes the patient's transition to home and empowers
them to improve their heart health. Advanced practice nurses contact patients
within days of discharge and facilitate daily medical monitoring, education,
and counseling. Patient-centered programs bring together all the medical
resources necessary to combat heart failure and the reduction in hospital
readmission rates has been significant. Heart failure clinics are based
at all RWJBarnabas Health hospitals.
Clinical trials provide patients with access for breakthrough medications,
devices, and therapies, while being continually monitored and evaluated.
Our participation in new cardiac stem cell research for patients with
refractory angina and chronic myocardial ischemia may someday help the
heart heal itself. Improved technology has made positive outcomes with
ECMO more likely both at our center and nationally, and has resulted in
increased referrals for this critical care.